Accord Healthcare, Inc.: Levothyroxine Sodium Tablets, Usp, 300 Mcg (0.3mg), 90 Tablets Bottles
Recall Summary Accord Healthcare is recalling Levothyroxine Sodium Tablets 300 mcg in 90-tablet bottles (NDC 16729-458-15) because the medication is subpotent—meaning it contains less active ingredient than it should. The affected product was distributed nationwide across all U.S. states. This is a Class II recall, indicating the product could cause adverse health effects in patients who rely on this thyroid medication.
- Recalling firm
- ACCORD HEALTHCARE, INC.
- Product
- Levothyroxine Sodium Tablets, USP, 300 mcg (0.3mg), 90 Tablets bottles, Rx only, Manufactured for: Accord Healthcare, Inc., Raleigh, NC 27617, Manufactured by: lntas Pharmaceuticals Limited, Camp Road, Selaqui, Dehradun-248 197, INDIA, NDC 16729-458-15.
- Reason
- Subpotent Drug
- Classification
- Class II
- Category
- drug recall
- Country
- United States
- Agency
- U.S. Food and Drug Administration
- Recall date
- 2026-06-08
- Status
- Ongoing
- Areas affected
- AL, AK, AZ, AR, CA, CO, CT, DE, FL, GA, HI, ID, ...
- Distribution
- US Nationwide.
Official recall notice from U.S. Food and Drug Administration
Recall details on Nibble Recalls: https://trynibble.app/recalls/e377dd2d-039c-400e-9c51-7b013794cca7